Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MT1 inhibitors(ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase inhibitors), MT2 inhibitors(metallothionein 2A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H25N3O6 |
InChIKeyAJPOWRPZSWEQQN-UHFFFAOYSA-N |
CAS Registry2813865-88-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep | Preclinical | FR | 25 Aug 2022 |